fda restrictions on compounding bpc-157 I am getting so many messages A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! BPC 157 Legal Status: FDA Regulations and Compounding An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA panel to consider easing restrictions on peptide production : NPR

SKU: 46603860242 · From astonvaughan.co.uk